Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 945-888-9 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2017-11-13 to 2018-01-15
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with generally accepted scientific standards and described in sufficient detail
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
- Report date:
- 2018
Materials and methods
- Objective of study:
- bioaccessibility (or bioavailability)
Test guideline
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- This report measured bioaccessibility of zirconium oxide, hafnium and ytterbium doped in in different artificial media: gastric juice, lysosomal, alveolar and perspiration fluids; representing ingestion, inhalation and dermic contact routes of exposure in humans.
- GLP compliance:
- yes
Test material
- Reference substance name:
- Zirconium oxide, hafnium and ytterbium doped
- EC Number:
- 945-888-9
- Molecular formula:
- Yb0.109Hf0.013Zr0.879O1.949
- IUPAC Name:
- Zirconium oxide, hafnium and ytterbium doped
Constituent 1
- Specific details on test material used for the study:
- - Batch No.: 7170403
- Source: H.C. Starck Surface Technology and Ceramic Powders GMBH, Germany - Radiolabelling:
- not specified
Test animals
- Details on test animals or test system and environmental conditions:
- Not applicable
Administration / exposure
- Route of administration:
- other: representing ingestion, inhalation and dermal routes of exposure in humans
- Vehicle:
- unchanged (no vehicle)
- Details on exposure:
- - Gastric bio-elution test: Metals or metal compounds are subjected to a media that mimics gastric juice, in terms of pH and body temperature (pH 1.5 and 37 °C), for an exposure time of 1 hour with agitation. Then the substances are incubated for another hour without agitation, before aliquots are taken, filtered and bio-accessible metals are quantified with an ICP-MS spectrometer.
- Lysosomal bio-elution test: Metals or metal substances are subjected to a media pH 4.5 – 5.0 that mimics intracellular conditions of phagocytosis in alveolar and interstitial macrophages. A bio-elution test of 3 days at 37 °C and 171 rpm agitation rate was performed. Samples are taken at 2, 24 and 72 hours of incubation, filtered and bio-accessible metals are quantified with an ICP-MS spectrometer.
- Alveolar bio-elution test: Metals or metal substances are subjected to a media that mimics alveolar fluid in the lung for 3 days at 37 °C and 171 rpm agitation rate. Samples are taken at 2, 24 hours and 72 hours of incubation, filtered and bio-accessible are metals quantified with an ICP-MS spectrometer.
- Sweat bio-elution test: Metals or metal substances are subjected to a media that mimics perspiration for 7 days at 30 °C and without agitation. Samples are taken at 24 hours and 168 hours of incubation, filtered and bioaccessible metals are quantified with an ICP-MS spectrometer.
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0.2 other: g / L
- Remarks:
- Gastric bio-elution test
- Dose / conc.:
- 2 other: g / L
- Remarks:
- Lysosomal bio-elution, Alveolar bio-elution and sweat bio-elution test
- No. of animals per sex per dose / concentration:
- Not applicable
- Positive control reference chemical:
- Not applicable
- Details on study design:
- - Gastric bio-elution test procedure:
A volume of 50 ml of gastric medium is added to 6 glass flasks of 250 ml. The vessels are pre-incubated in an orbital shaker at about 60 rpm, until equilibrium temperature has been reached (37 ºC), pH and dissolved Oxygen are measured. Before adding the metal substance, 15 mL samples are withdrawn per flask, filtered through 0.2 μm PTFE membranes and separate to measure the metal concentration (time 0, detection of possible contamination). Fresh media is added back to complete the 50 ml. In three of the flasks the metal substance is added at 0.2 g/L sample loading and the agitation rate set to 171 rpm. The 2 hours of incubation are performed in dark conditions, the first hour with agitation and the second hour without agitation. As soon as the incubation time is completed, one sample is taken from each flask and filtered through 0.2 μm PTFE membranes. To preserve sample integrity: After each sample is collected, the samples are stored at 4 °C
in dark conditions until the analysis is performed (within 2 weeks).
- Lysosomal bio-elution test procedure:
A volume of 50 ml of lysosomal media is added to 18 glass flasks of 250 ml. The vessels are pre-incubated in an orbital shaker at about 60 rpm, until equilibrium temperature has been reached (37 ºC), pH and dissolved Oxygen are measured. Before adding the metal substance, 15 mL samples are withdrawn per flask, filtered through 0.2 μm PTFE membranes and separate to measure the metal concentration (time 0, detection of possible contamination). Fresh media is added back to complete the 50 ml. In nine of the flasks the metal substance is added at 2 g/L sample loading and the agitation rate set to 171 rpm. The 3 days of incubation are performed in dark conditions. After 2 hours of incubation one 15 ml aliquot is taken from each of 3 blank flasks and 3 sample flasks. The
vessels are discarded and the aliquots, filtered through 0.2 μm PTFE membranes. The sampling procedure is repeated at 24 and 72 hours of incubation. To preserve sample integrity: After each sample is collected, 3 drops of concentrated Nitric Acid (high purity, ultra trace quality) are added. The samples are stored at 4 °C in dark conditions until the analysis is performed (within 2 weeks).
- Alveolar bio-elution test procedure:
A volume of 50 ml of alveolar media is added to 18 glass flasks of 250 ml. The vessels are pre-incubated in an orbital shaker at about 60 rpm, until equilibrium temperature has been reached (37 ºC), pH and dissolved Oxygen are measured. Before adding the metal substance, 15 mL samples are withdrawn per flask,filtered through 0.2 μm PTFE membranes and separate to measure the metal concentration (time 0, detection of possible contamination). Fresh media is added back to complete the 50 ml. nine of the flasks the metal substance is added at 2 g/L sample loading and the agitation rate set to 171 rpm. The 3 days of incubation are performed in dark conditions. After 2 hours of incubation one 15 ml aliquot is taken from each of 3 blank flasks and 3 sample flasks. The vessels are discarded and the aliquots, filtered through 0.2 μm PTFE membranes. The sampling procedure is repeated at 24 and 72 hours of incubation. To preserve sample integrity: After each sample is collected, 3 drops of concentrated Nitric Acid (high purity, ultra trace quality) are added. The samples are stored at 4 °C in dark
conditions until the analysis is performed (within 2 weeks).
- Sweat bio-elution test procedure:
A volume of 50 ml of perspiration media is added to 12 glass flasks of 250 ml. The vessels are pre-incubated in an orbital shaker at about 60 rpm, until equilibrium temperature has been reached (30 ºC), pH and dissolved Oxygen is measured. Before adding the metal substance, 15 mL samples are withdrawn per flask, filtered through 0.2 μm PTFE membranes and separate to measure the metal concentration (time 0, detection of possible contamination). Fresh media is added back to complete the 50 ml. In six of the flasks the metal substance is added at 2 g/L sample loading and the vessel swirled to mix the compound with the media. The 7 days of incubation without agitation are performed in dark conditions. After 24 hours of incubation one 15 ml aliquot is taken from each of 3 blank flasks and 3 sample flasks. The vessels are discarded and the aliquots, filtered through 0.2 μm PTFE membranes. The rest of the flasks continue the test until the 7 days of incubation are completed, and once again 15 ml blank and sample aliquots are taken and filtered. To preserve sample integrity: After each sample is collected, 3 drops of concentrated Nitric Acid (high purity, ultra trace quality) are added. The samples are stored at 4 °C in dark conditions until the analysis is performed (within 2 weeks). - Details on dosing and sampling:
- Not applicable
- Statistics:
- Not applicable
Results and discussion
Bioaccessibility (or Bioavailability)
- Bioaccessibility (or Bioavailability) testing results:
- See Tables under "Any other information on results incl. tables"
Any other information on results incl. tables
Table 1: Perspiration bio-elution test
Perspiration test parameters |
Hafnium, µg/L |
Hafnium, µg / g |
||||||
Hf |
Time, hr |
Temp, °C |
Ph |
Mean; µg / L |
St. Dev |
CV, % |
Mean, µg /g |
CV, % |
|
Before |
30 |
6.58 |
BDL |
- |
- |
- |
- |
|
24 |
30 |
6.01 |
BDL |
- |
- |
- |
- |
|
168 |
30 |
5.55 |
BDL |
- |
- |
- |
- |
Perspiration test parameters |
Ytterbium, µg/L |
Ytterbium µg / g |
||||||
Yb |
Time, hr |
Temp, °C |
Ph |
Mean; µg / L |
St. Dev |
CV, % |
Mean |
CV, % |
|
Before |
30 |
6.58 |
BDL |
- |
- |
- |
- |
|
24 |
30 |
6.01 |
3.242 |
0.32 |
10 |
1.621 |
10 |
|
168 |
30 |
5.55 |
5.524 |
0.21 |
400 |
2.762 |
4 |
Perspiration test parameters |
Zirconium, µg/L |
Zirconium µg / g |
||||||
Zr |
Time, hr |
Temp, °C |
Ph |
Mean; µg / L |
St. Dev |
CV, % |
Mean |
CV, % |
|
Before |
30 |
6.58 |
BDL |
- |
- |
- |
- |
|
24 |
30 |
6.01 |
0.02 |
0.01 |
28 |
- |
- |
|
168 |
30 |
5.55 |
0.22 |
0.05 |
21 |
0.11 |
21 |
Table 2: Alveolar bio-elution test
Alveolar test parameters |
Hafnium, µg/L |
Hafnium, µg / g |
||||||
Hf |
Time, hr |
Temp, °C |
Ph |
Mean; µg / L |
St. Dev |
CV, % |
Mean |
CV, % |
|
Before |
37 |
7.45 |
BDL |
- |
- |
- |
- |
|
2 |
37 |
7.47 |
BDL |
- |
- |
- |
- |
|
24 |
37 |
7.40 |
BDL |
- |
- |
- |
- |
|
72 |
37 |
7.29 |
0.11 |
0.03 |
26 |
- |
- |
Alveolar test parameters |
Ytterbium, µg/L |
Ytterbium µg / g |
||||||
Yb |
Time, hr |
Temp, °C |
Ph |
Mean; µg / L |
St. Dev |
CV, % |
Mean |
CV, % |
|
Before |
37 |
7.45 |
BDL |
- |
- |
- |
- |
|
2 |
37 |
7.47 |
0.106 |
0.08 |
72 |
0.053 |
72 |
|
24 |
37 |
7.40 |
0.095 |
0.00 |
2 |
0.048 |
2 |
|
72 |
37 |
7.29 |
2.846 |
0.24 |
8 |
1.423 |
8 |
Alveolar test parameters |
Zirconium, µg/L |
Zirconium µg / g |
||||||
Zr |
Time, hr |
Temp, °C |
pH |
Mean; µg / L |
St. Dev |
CV, % |
Mean |
CV, % |
|
Before |
37 |
7.45 |
BDL |
- |
- |
- |
- |
|
2 |
37 |
7.47 |
0.5 |
0.34 |
65 |
- |
- |
|
24 |
37 |
7.40 |
1.2 |
0.34 |
29 |
0.6 |
29 |
|
72 |
37 |
7.29 |
5.4 |
1.14 |
21 |
2.7 |
21 |
Table 3: Lysosomal bio-elution test
Lysosomal test parameters |
Hafnium, µg/L |
Hafnium, µg / g |
||||||
Hf |
Time, hr |
Temp, °C |
Ph |
Mean; µg / L |
St. Dev |
CV, % |
Mean |
CV, % |
|
Before |
37 |
4.53 |
BDL |
- |
- |
- |
- |
|
2 |
37 |
4.50 |
BDL |
- |
- |
- |
- |
|
24 |
37 |
4.55 |
0.02 |
0.006 |
30 |
- |
- |
|
72 |
37 |
4.55 |
0.09 |
0.005 |
5 |
0.04 |
5 |
Lysosomal test parameters |
Ytterbium, µg/L |
Ytterbium µg / g |
||||||
Yb |
Time, hr |
Temp, °C |
Ph |
Mean; µg / L |
St. Dev |
CV, % |
Mean |
CV, % |
|
Before |
37 |
4.53 |
0.002 |
0.001 |
50 |
- |
- |
|
2 |
37 |
4.50 |
2.990 |
0.192 |
6 |
1.495 |
6 |
|
24 |
37 |
4.55 |
8.314 |
0.496 |
6 |
4.157 |
6 |
|
72 |
37 |
4.55 |
8.943 |
1.089 |
12 |
4.472 |
12 |
Lysosomal test parameters |
Zirconium, µg/L |
Zirconium µg / g |
||||||
Zr |
Time, hr |
Temp, °C |
pH |
Mean; µg / L |
St. Dev |
CV, % |
Mean |
CV, % |
|
Before |
37 |
4.53 |
BDL |
- |
- |
- |
- |
|
2 |
37 |
4.50 |
1.5 |
0.05 |
3 |
0.8 |
3 |
|
24 |
37 |
4.55 |
4.3 |
0.10 |
2 |
2.2 |
2 |
|
72 |
37 |
4.55 |
5.5 |
0.31 |
6 |
2.8 |
6 |
Table 4: Gastric bio-elution test
Gastric test parameters |
Hafnium, µg/L |
Hafnium, µg / g |
||||||
Hf |
Time, hr |
Temp, °C |
Ph |
Mean; µg / L |
St. Dev |
CV, % |
Mean |
CV, % |
|
Before |
37 |
1.50 |
BDL |
- |
- |
- |
- |
|
2 |
37 |
1.51 |
BDL |
- |
- |
- |
- |
Gastric test parameters |
Ytterbium, µg/L |
Ytterbium µg / g |
||||||
Yb |
Time, hr |
Temp, °C |
Ph |
Mean; µg / L |
St. Dev |
CV, % |
Mean |
CV, % |
|
Before |
37 |
1.50 |
BDL |
- |
- |
- |
- |
|
2 |
37 |
1.51 |
0.485 |
0.021 |
4 |
2.427 |
4 |
Gastric test parameters |
Zirconium, µg/L |
Zirconium µg / g |
||||||
Zr |
Time, hr |
Temp, °C |
pH |
Mean; µg / L |
St. Dev |
CV, % |
Mean |
CV, % |
|
Before |
37 |
1.50 |
BDL |
- |
- |
- |
- |
|
2 |
37 |
1.51 |
0.01 |
0.006 |
66 |
0.05 |
66 |
Applicant's summary and conclusion
- Conclusions:
- The test item showed low solubility.
- Executive summary:
In this study, bio-elution tests in four different synthetic media, including: gastric, lysosomal, alveolar and perspiration, were performed to Ytterbium stabilized Zirconium and Hafnium Oxide. The results of the bio-elution tests (table 1), show low solubility of the metallic components of the test item: zirconium, ytterbium and hafnium; in the set of fluids assayed; with the higher metal release values found in artificial lysosomal fluid after 72 hours of incubation, with a solubility of 0.003 % (w/w) for Yb and 0.0004% (w/w) for Zr.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.